Xcelgenin PQ-DP
Natural health product licensed in Canada
- Licence holder
- PLC Health Solutions Inc.
- NPN or DIN-HM
- 80040322
- Status
- Active licence
- Licence date
- 25 February 2013
- Revision date
- Not provided
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax quinquefolius Source : Panax quinquefolius root Extraction ratio : 10:1 Dry plant equivalent : 0.15 g | 0.015 g | Not calculated |
Non-medicinal ingredients
Poloxamère 188, Poly(éthylène glycol)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 10 Pilule ; maximum: 15 Pilule | minimum: 2 days ; maximum: 3 days |
Uses authorised in Canada
Traditionally used in Herbal Medicine to help maintain a healthy immune system.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking blood thinners or digoxin.
Source
Official Health Canada record, licence 80040322
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.